Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral iron dosing frequency in women with iron deficiency anemia
IRCT20251122068082N1Phase 4Completed
- Sponsor
- Jahrom University of Medical Sciences
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Iron in iron deficiency anemia (IDA) (3 arms), sponsored by Jahrom University of Medical Sciences. Primary endpoints: Mean hemoglobin change from baseline to week 8 and Frequency and severity of gastrointestinal adverse effects. Started Jan 2026; status: completed.
02
Drugs
Iron
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on IRCT20251122068082N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251122068082N1.